You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020113015
Dec 202060017
Jan 20212105
Feb 20212209
Mar 202164015
Apr 20213005
May 2021208
Jun 2021006
Jul 2021005
Aug 2021008
Sep 2021004
Oct 202156019
Nov 20211209
Dec 20211601
Jan 2022801
Feb 20221903
Mar 20221003
Apr 20223302
May 20222004
Jun 20221904
Jul 20221600
Aug 20221604
Sep 20221902
Oct 20222001
Nov 20221705
Dec 20221001
Jan 20231600
Feb 20232800
Mar 20231605
Apr 20233201
May 20231003
Jun 20231402
Jul 20231204
Aug 20231201
Sep 2023401
Oct 20231603
Nov 20231403
Dec 20234802
Jan 20241600
Feb 20242601
Mar 20242903
Apr 20241000
May 20242600
Jun 20242603
Jul 2024800
Aug 20242002
Sep 20241401
Oct 20242007
Nov 2024801
Dec 2024803
Jan 202522011
Feb 2025002
Mar 2025003
Apr 2025005
May 2025003
Jun 2025002
Total10580228